Pradaxa Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

NOAC Portuguese Real World Study
Conditions:   Stroke;   Systemic Embolism;   Major Bleeding Interventions:   Drug: Apixaban;   Drug: dabigatran;   Drug: rivaroxaban;   Drug: VKAs Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Condition:   Acute Ischemic Stroke Interventions:   Drug: LT3001 drug product;   Drug: Placebo;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Apixaban;   Drug: Dabigatran Sponsor:   Lumosa Therapeutics Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

NOAC Portuguese Real World Study
Conditions:   Stroke;   Systemic Embolism;   Major Bleeding Interventions:   Drug: Apixaban;   Drug: dabigatran;   Drug: rivaroxaban;   Drug: VKAs Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Condition:   Acute Ischemic Stroke Interventions:   Drug: LT3001 drug product;   Drug: Placebo;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Apixaban;   Drug: Dabigatran Sponsor:   Lumosa Therapeutics Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

NOAC Portuguese Real World Study
Conditions:   Stroke;   Systemic Embolism;   Major Bleeding Interventions:   Drug: Apixaban;   Drug: dabigatran;   Drug: rivaroxaban;   Drug: VKAs Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Condition:   Acute Ischemic Stroke Interventions:   Drug: LT3001 drug product;   Drug: Placebo;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Apixaban;   Drug: Dabigatran Sponsor:   Lumosa Therapeutics Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

NOAC Portuguese Real World Study
Conditions:   Stroke;   Systemic Embolism;   Major Bleeding Interventions:   Drug: Apixaban;   Drug: dabigatran;   Drug: rivaroxaban;   Drug: VKAs Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Condition:   Acute Ischemic Stroke Interventions:   Drug: LT3001 drug product;   Drug: Placebo;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Apixaban;   Drug: Dabigatran Sponsor:   Lumosa Therapeutics Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2021 Category: Research Source Type: clinical trials